Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 28.99
-0.11 (-0.38%)
May 20, 2026, 11:30 AM CST
SHA:688321 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 98.39 | 50.96 | -114.57 | 88.84 | 17.48 | 21.96 |
Depreciation & Amortization | 70.05 | 70.05 | 59.03 | 43.73 | 38.72 | 19.62 |
Other Amortization | 2.84 | 2.84 | 2.46 | 1.89 | 3.74 | 1.65 |
Loss (Gain) From Sale of Assets | - | - | -0 | - | 0.71 | 0.13 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | 90.12 | 0.03 | - | - |
Loss (Gain) From Sale of Investments | 24.84 | 24.84 | 21.6 | -282.03 | -2.4 | -5.52 |
Provision & Write-off of Bad Debts | 3.18 | 3.18 | -2.69 | 4.33 | 0.55 | 0.05 |
Other Operating Activities | -20.27 | 22.79 | 17.73 | -22.07 | 11 | 2.12 |
Change in Accounts Receivable | -160.14 | -160.14 | -19.62 | -59.12 | -42.46 | -73.72 |
Change in Inventory | -16.84 | -16.84 | 6.29 | -18.66 | -19.41 | -1.1 |
Change in Accounts Payable | 102.65 | 102.65 | 3.08 | 49.75 | 42.64 | 182.88 |
Change in Other Net Operating Assets | -1.97 | -1.97 | -3.37 | -10.02 | -4.64 | -4.59 |
Operating Cash Flow | 101.33 | 96.97 | 76.13 | -157.27 | 43.3 | 124.78 |
Operating Cash Flow Growth | 66.99% | 27.37% | - | - | -65.30% | 33.29% |
Capital Expenditures | -261.67 | -178.6 | -268.49 | -229.03 | -400.17 | -288.46 |
Sale of Property, Plant & Equipment | 0.03 | 0.01 | 0 | 0.45 | 0.29 | 0.01 |
Divestitures | - | - | - | -41.35 | - | - |
Investment in Securities | -613.79 | -57.87 | -40.47 | -119.14 | -407.46 | 245.55 |
Other Investing Activities | 20.73 | 18.84 | 12.92 | 14.06 | 5.63 | 12.28 |
Investing Cash Flow | -854.7 | -217.62 | -296.03 | -375.01 | -801.7 | -30.62 |
Long-Term Debt Issued | - | 491.9 | 408.19 | 444.21 | 541 | 174.92 |
Long-Term Debt Repaid | - | -315.11 | -190.19 | -221.73 | -260.34 | -96.55 |
Net Debt Issued (Repaid) | 97.06 | 176.79 | 217.99 | 222.48 | 280.66 | 78.37 |
Issuance of Common Stock | 938.34 | - | - | 178.88 | 488.34 | 18.01 |
Repurchase of Common Stock | -15 | -15 | -15 | - | - | -154.59 |
Common Dividends Paid | -31.6 | -31.74 | -27.63 | -18.74 | -12.17 | -4.22 |
Other Financing Activities | -6.55 | -2.45 | - | - | 104.46 | -0.89 |
Financing Cash Flow | 982.26 | 127.6 | 175.36 | 382.62 | 861.29 | -63.31 |
Foreign Exchange Rate Adjustments | -1.45 | -0.81 | 0.39 | 1.08 | 12.23 | -2.25 |
Net Cash Flow | 227.43 | 6.14 | -44.15 | -148.58 | 115.11 | 28.6 |
Free Cash Flow | -160.34 | -81.64 | -192.36 | -386.3 | -356.87 | -163.68 |
Free Cash Flow Margin | -15.96% | -8.97% | -29.24% | -73.76% | -67.34% | -38.03% |
Free Cash Flow Per Share | -0.39 | -0.20 | -0.47 | -0.95 | -0.88 | -0.40 |
Cash Income Tax Paid | 58.18 | 47.43 | 27.68 | 40.02 | -7.9 | 14.06 |
Levered Free Cash Flow | 53.68 | 125.83 | -607.87 | -507.91 | -232.05 | -292.18 |
Unlevered Free Cash Flow | 75.99 | 148.14 | -586.46 | -486.11 | -219.46 | -289.23 |
Change in Working Capital | -77.76 | -77.76 | 2.44 | 8 | -26.51 | 84.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.